RAD51 is overexpressed in many cancer cell lines [25, 26] and primary tumors, including breast [27], pancreatic [28], prostate [29], non-small cell lung [30], and esophageal cancers [31, 32]. This evidence concerns the gene RAD51 and esophageal cancer.